Sellas Life Sciences Group Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Sellas Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
/ 
Frequently asked questions
To buy Sellas Life Sciences Group Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Sellas Life Sciences Group Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Sellas Life Sciences Group Inc. is SLS:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Sellas Life Sciences Group Inc. has its primary listing on NASDAQ (Small cap). You can trade Sellas Life Sciences Group Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Sellas Life Sciences Group Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Sellas Life Sciences Group Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Sellas Life Sciences Group Inc..